Giorgia Guglielmi

Synthetic microbial communities may help to fight C. difficile infection

Nutrient competition is the main mechanism of C. difficile inhibition, hinting at the potential for targeted therapies with probiotics instead of traditional FMT.

Boosting microbial diversity on spacecraft could improve astronauts’ health

Introducing more natural microbes could improve astronauts’ health.

New tools reveal insights into Bifidobacterium’s role in gut health

Researchers have developed new tools to better understand the role of Bifidobacterium breve, revealing its competitive growth strategies and potential for supporting the immune system.

Delayed gut microbiota maturation in cystic fibrosis may contribute to health issues

Delayed microbiota maturation in infants with cystic fibrosis could contribute to disease complications, highlighting potential therapeutic targets.

How exercise boosts gut health, helping prevent chronic diseases

Understanding the complex interactions between exercise, diet and gut health can help to develop approaches to influence the gut microbiota, boost immunity and prevent or manage gastrointestinal diseases.

Engineered viruses target gut bacteria to deliver drugs for inflammation and obesity

Phages could be used as a drug delivery system for conditions such as inflammation and obesity.

Microbiota signatures may help identify sexual assault perpetrators

Microbiota analysis could help sexual assault investigations by detecting microbial markers of contact, even in cases where traditional DNA evidence is lacking.

Microbiota-derived molecule boosts effectiveness of Crohn’s disease treatment

L-ornithine can be an additional therapy to boost the efficacy of ustekinumab in people with Crohn’s disease.

The need for diversity in vaginal microbiota research

By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.

Gut microbes linked to inflammatory bowel diseases worsen colitis in mice

Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top